NCT06106152 2024-03-26WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal AntibodySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase EARLY_PHASE1 Unknown20 enrolled